Rising incomes and a growing middle class in China is boosting investment into healthcare, pharmacy and self-care. This was recently highlighted by the announcement that a Chinese investor group will be acquiring the condom division of Ansell Ltd, the world’s second-largest condom maker, for USD 600 million. The amount represents 16 times the division’s earnings…
The healthcare system in GCC territories has become a growing concern in recent years. Beyond problems such as a growing population and a higher average lifespan, countries’ such as Saudi Arabia and Qatar have become host to some of the highest rates of chronic lifestyle diseases in the world. In the UAE, diabetes affects 19%…
UAE’s Mubadala Development Co have announced an investment coalition with the Chinese conglomerate HNA Group, revealing very few details about specific future investments, and leaving much excitement to the imagination. Between the two investor groups, new projects could have access to anything within the $100 billion worth of assets at the disposal of HNA or…
The transformation of GCC economies, attempting to break from the traditional oil based capital, has been underway for some time. Looking towards a knowledge and technology based portfolio has proven fruitful for a number of countries, particularly within the healthcare sector of the UAE. Healthcare is one of the principle concerns facing the UAE; aging…
China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to source solutions and expertise that could meet the needs of the Saudi market. Healthcare is…
Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…
In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…
I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…